Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

被引:0
|
作者
Vaz, Maria Angeles
Girones, Regina
Del Barco, Sonia
Sanchez, Juan Manuel Sepulveda
Alonso, Miriam
Pineda, Estela
Balana, Carmen
Martinez-Garcia, Maria
机构
[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ & Politecn La Fe, Med Oncol Serv, Valencia, Spain
[3] Inst Catal Oncol Girona, Med Oncol Serv, Girona, Spain
[4] Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain
[5] Hosp Virgen Rocio, Med Oncol Serv, Seville, Spain
[6] Hosp Clin Barcelona, Med Oncol Serv, Barcelona, Spain
[7] Inst Catal Oncol, Med Oncol Serv, Badalona, Spain
[8] Hosp Mar, Med Oncol Serv, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2060
引用
收藏
页数:1
相关论文
共 50 条
  • [31] PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Weathers, Shiao-Pei
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca
    Liu, Diane
    Sanqui, Edmund
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara
    de Groot, John
    NEURO-ONCOLOGY, 2020, 22 : 35 - 35
  • [32] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Omuro, Antonio Marcilio Padula
    Beal, Kathryn
    McNeill, Katharine Anne
    Thomas, Alissa A.
    Lin, Xuling
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Yamada, Yoshiya
    Gorman, Greg
    Lamson, Michael
    Bavisotto, Linda M.
    Karmali, Rashida A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
    Omuro, Antonio
    Beal, Kathryn
    Gutin, Philip
    Karimi, Sasan
    Correa, Denise D.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Chan, Timothy A.
    Gavrilovic, Igor T.
    Nolan, Craig
    Hormigo, Adilia
    Lassman, Andrew B.
    Mellinghoff, Ingo
    Grommes, Christian
    Reiner, Anne S.
    Panageas, Katherine S.
    Baser, Raymond E.
    Tabar, Viviane
    Pentsova, Elena
    Sanchez, Juan
    Barradas-Panchal, Renata
    Zhang, Jianan
    Faivre, Geraldine
    Brennan, Cameron W.
    Abrey, Lauren E.
    Huse, Jason T.
    CLINICAL CANCER RESEARCH, 2014, 20 (19) : 5023 - 5031
  • [34] Bevacizumab in Combination With Radiotherapy and Temozolomide for PatientsWith Newly Diagnosed Glioblastoma Multiforme
    van Linde, Myra E.
    Verhoeff, Joost J. C.
    Richel, Dirk J.
    van Furth, Bwouter R.
    Reijneveld, Jaap C.
    Verheul, Henk M. W.
    Stalpers, Lukas J. A.
    ONCOLOGIST, 2015, 20 (02): : 107 - 108
  • [35] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [36] Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Saris, G
    Beroukas, K
    Karageorgis, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2372 - 2377
  • [37] Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma
    Reardon, David A.
    Lassman, Andrew B.
    van den Bent, Martin
    Kumthekar, Priya
    Merrell, Ryan
    Scott, Andrew M.
    Fichtel, Lisa
    Sulman, Erik P.
    Gomez, Erica
    Fischer, JuDee
    Lee, Ho-Jin
    Munasinghe, Wijith
    Xiong, Hao
    Mandich, Helen
    Roberts-Rapp, Lisa
    Ansell, Peter
    Holen, Kyle D.
    Gan, Hui K.
    NEURO-ONCOLOGY, 2017, 19 (07) : 965 - 975
  • [38] Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
    Perez-Larraya, Jaime Gallego
    Ducray, Francois
    Chinot, Olivier
    Catry-Thomas, Isabelle
    Taillandier, Luc
    Guillamo, Jean-Sebastien
    Campello, Chantal
    Monjour, Annick
    Cartalat-Carel, Stephanie
    Barrie, Maryline
    Huchet, Aymeri
    Beauchesne, Patrick
    Matta, Mona
    Mokhtari, Karima
    Tanguy, Marie-Laure
    Honnorat, Jerome
    Delattre, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 3050 - 3055
  • [39] Phase II trial of bevacizumab and temozolomide for upfront treatment of elderly patients with newly diagnosed glioblastoma.
    Nghiemphu, Phioanh Leia
    Bahng, Hye Hyun
    Lai, Albert
    Faiq, Nadia
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Cynthia Elizabeth
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
    Chinot, O. L.
    Wick, W.
    Saran, F.
    Mason, W. P.
    Henriksson, R.
    Nishikawa, R.
    Zeaiter, A. H.
    Moore, N.
    Das, A.
    Cloughesy, T. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)